About this trial
To compare the intraoperative effects of Dexmedetomidine and Magnesium Sulfate infusion on intracranial pressure and cerebral perfusion pressure in adult patients undergoing craniotomy
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-65 years
Elective craniotomy for supratentorial pathology
No contraindication to lumbar drain insertion
Baseline mental status is stable, allowing for a reliable postoperative neurological evaluation can be done
Disqualifiers
Coagulopathy or current anticoagulation
Severe renal or hepatic dysfunction
Known allergy to study medications
traumatic brain injury
Trial design
Parallel
Treatments tested in this trial
Dexamedomedine
DrugGroup A (the Dexmedetomidine group): Dexmedetomidine: loading dose 1 µg/kg IV over 10 min after induction and then maintenance dose 0.2- 0.7 µg/kg/hr based on hemodynamic response.
MgSO4
DrugMagnesium Sulfate: Used as an IV loading dose at 20 mg/kg IV over 17 minutes as an induction agent, followed by maintenance of 10 mg/kg/h
Treatment groups
Trial outcomes
Primary outcomes
Change in ICP and CPP in craniotomy
compare the intraoperative intracranial pressure (ICP) and cerebral perfusion pressure (CPP) effects of dexmedetomidine and magnesium sulfate infusion in a comparative study to determine the efficacy in adult patients undergoing craniotomy, continuous measurement was achieved with the help of a lumbar drain catheter.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: